신경과학 시장 보고서 : 구성요소, 기술, 최종사용자, 지역별(2025-2033년)

The global neuroscience market size reached USD 35.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 48.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.1% during 2025-2033. Increasing prevalence of neurological disorders, rising investment in research and development (R&D), technological advancements in neuroimaging tools, growing awareness of mental health issues, expanding applications in neuroinformatics and neuroprosthetics, burgeoning aging populations, and supportive government policies are some of the factors facilitating the market growth.

Neuroscience refers to the scientific study of the brain and nervous system. It is an interdisciplinary science that works closely with other disciplines, including cellular and molecular biology, physiology, anatomy, and human behavior and cognition. It provides valuable insights into the anatomy of the brain and neurological, physical, and psychological functioning. It also assists neurologists in understanding various factors that can aid in the development of medications and strategies to treat and prevent numerous neurological disorders. Nowadays, researchers and neuroscientists are increasingly employing advanced imaging techniques for identifying neural networks involved in understanding disease pathways, early disease diagnosis, and cognitive processes.

Neuroscience Market Trends:

The increasing number of deaths due to various neurological disorders, such as Parkinson's disease, Alzheimer's, schizophrenia, and other brain-related conditions, represents the primary factor driving the market growth. Besides this, the escalating demand for neuroimaging devices and the ongoing brain mapping research and investigation projects are other major growth-inducing factors. Additionally, the governments of various nations are taking favorable initiatives to spread awareness about neurological diseases and the available treatment options. Along with this, the rising usage of microscopy, optogenetics, magnetic resonance imaging (MRI), and electrophysiology instruments in the diagnosis of several neurological disorders is catalyzing the market growth. Furthermore, the leading players are developing innovative medical devices that offer enhanced efficiency and patient compliance to expand their product portfolio and gain a competitive edge. Moreover, the growing awareness regarding the benefits of advanced neuroscience devices, such as the combination of other imaging devices along with the MRI and neuro microscopes over conventional standalone imaging devices, is propelling the market growth. Other factors, including the surging government funding for research and development (R&D) activities, advancements in the field of neuroscience and neuro-technology, increasing healthcare expenditure, rising geriatric population, and improving healthcare infrastructure, are also providing a positive thrust to the market growth.

Key Market Segmentation:

Breakup by Component:

• Instruments and Consumables
• Software and Services

Breakup by Technology:

• Brain Imaging
• Neuro-Microscopy
• Electrophysiology
• Neuroproteomic Analysis
• Animal Behaviour Analysis
• Others

Breakup by End User:

• Hospitals
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd. and Siemens AG.

Key Questions Answered in This Report

• 1.What was the size of the global neuroscience market in 2024?
• 2.What is the expected growth rate of the global neuroscience market during 2025-2033?
• 3.What are the key factors driving the global neuroscience market?
• 4.What has been the impact of COVID-19 on the global neuroscience market?
• 5.What is the breakup of the global neuroscience market based on the component?
• 6.What is the breakup of the global neuroscience market based on the technology?
• 7.What are the key regions in the global neuroscience market?
• 8.Who are the key players/companies in the global neuroscience market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Neuroscience Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Instruments and Consumables
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Software and Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Brain Imaging
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Neuro-Microscopy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Electrophysiology
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Neuroproteomic Analysis
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Animal Behaviour Analysis
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diagnostic Laboratories
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Research and Academic Institutes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Alpha Omega Engineering
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Biobserve GmbH
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Blackrock Neurotech
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Doric Lenses Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 General Electric Company
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Kernel
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Laserglow Technologies
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Mightex Systems
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 NeuroNexus Technologies Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Noldus Information Technology B.V.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Plexon Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Prizmatix Ltd.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Siemens AG
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis